Bryan, Garnier & Co's News Fresenius Med. Care: CMS final rule does not impact guidance nor estimates BUY Top Picks, Fair Value EUR90 (+11%) News published on October Friday 30, 2015 Share on For more information, please contact marketing@bryangarnier.com